Charles River Labs Intl buy Wells Fargo & Company
Start price
22.09.23
/
50%
€188.80
Target price
22.09.24
€257.73
Performance (%)
-1.59%
End price
23.09.24
€185.80
Summary
This prediction ended on 23.09.24 with a price of €185.80. With a performance of -1.59%, the BUY prediction for Charles River Labs Intl by Wells_Fargo___Compan closed slightly in the red. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Charles River Labs Intl | 2.754% | 2.754% | 33.798% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at Wells Fargo & Company from $280.00 to $275.00. They now have an "overweight" rating on the stock.
Ratings data for CRL provided by MarketBeat
In the thread Trading Charles River Labs Intl
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten